Title |
A proof of concept phase I/II pilot trial of LSD1 inhibition by tranylcypromine combined with ATRA in refractory/relapsed AML patients not eligible for intensive therapy |
|---|---|
Involved |
on behalf of the Study Alliance Leukemia (SAL) (Verfasser)
Maxi Wass (Verfasser) Stefanie Göllner (Verfasser) Birgit Besenbeck (Verfasser)
Richard Friedrich Schlenk (Verfasser)
Petra Mundmann (Verfasser) Joachim Rudolf Göthert (Verfasser) Richard Noppeney (Verfasser) Christoph Schliemann (Verfasser) Jan-Henrik Mikesch (Verfasser) Georg Lenz (Verfasser) Martin Dugas (Verfasser) Martin Wermke (Verfasser) Christoph Röllig (Verfasser) Martin Bornhäuser (Verfasser) Hubert Serve (Verfasser) Uwe Platzbecker (Verfasser) Kathrin Foerster (Verfasser) Jürgen Burhenne (Verfasser) Walter E. Haefeli (Verfasser) Lutz P. Müller (Verfasser) Mascha Binder (Verfasser) Caroline Pabst (Verfasser) Carsten Müller-Tidow (Verfasser) SpringerLink (Online service) (Sonstige) |
Published in |
Leukemia : normal and malignant hemopoiesis ; a peer-reviewed journal 35, 3, 19.6.2020, date:3.2021, Seite 701-711 |
Published |
2020 |
Language |
|
Country |
|
Topic |
|
Subject |
Public Health.
Internal Medicine. Intensive Care Medicine. Cancer Biology.
Oncology.
Hematology. |
DDC notation |
|
Persistent identifier |
urn:nbn:de:101:1-2506231213187.339568661316 (URN) |
Record ID |
1369433271 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: